Circulation 2008-09-02

Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".

Tine L De Backer, Robert H Vander Stichele, Luc M Van Bortel

Index: Circulation 118(10) , e151, (2008)

Full Text: HTML

Abstract


Related Compounds

Related Articles:

Buflomedil: potential new indications for an old agent.

2009-06-01

[Int. Angiol. 28(3) , 170-4, (2009)]

Vasoactive agent buflomedil up-regulated expression of vascular endothelial growth factor in a rat model of sciatic nerve crush injury.

2012-01-01

[Indian J. Pharmacol. 44(4) , 480-4, (2012)]

[Addition of antithrombosis in situ in the case of digital replantation: preliminary prospective study of 13 cases].

2010-10-01

[Chir. Main 29(5) , 326-31, (2010)]

[Multicentric study of thrombosis prevention in upper-extremity microsurgery. Survey at the Fesum centers].

2010-04-01

[Chir. Main 29(2) , 100-8, (2010)]

Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy.

2011-04-01

[Int. Angiol. 30(2) , 164-71, (2011)]

More Articles...